Format

Send to

Choose Destination
Dev Med Child Neurol. 1994 Jun;36(6):484-6.

Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Author information

1
Department of Pediatrics and Neurology, US Naval Hospital, Portsmouth, VA 23708.

Abstract

Ten developmentally delayed children with excessive drooling were randomized in a double-blind, placebo-controlled study to assess the efficacy and safety of transdermal scopolamine. Over half of the patients had a statistically significant reduction in drooling, and one-third had cessation of drooling, while wearing the scopolamine patch. This short-term study supports earlier reports of the safety and efficacy of transdermal scopolamine for reducing excessive drooling in developmentally disabled children.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center